Harvoni is the brand name for the ledipasvir/sofosbuvir combination. The “generic name” typically refers to the active ingredients: ledipasvir + sofosbuvir. Availability of generic equivalents varies by country, regulatory status, and access pathways. If a generic is used, it should be reputable and properly regulated, with clinician-guided dosing, interaction screening, and monitoring.